Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

Blood - 28 Jul 2011

Clark William B, Brown-Gentry Kristin D, Crawford Dana C, Fan Kang-Hsien, Snavely Jennifer, Chen Heidi, Savani Bipin N, Kassim Adetola, Greer John P, Schuening Friedrich G, Engelhardt Brian G, Jagasia Madan H

Abstract excerpt

B-cell activating factor (BAFF) single nucleotide polymorphisms (SNPs) are associated with autoimmune diseases. Because patients with classic and overlap chronic GVHD (cGVHD) have features of autoimmune diseases, we studied the association of recipient and/or donor BAFF SNPs with the phenotype of GVHD after allogeneic stem cell transplantation. Twenty tagSNPs of the BAFF gene were genotyped in 164 recipient/donor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to B-Cell Activating Factor

Share to Graft vs Host Disease

Share to Hematopoietic Stem Cell Transplantation

Share to Polymorphism, Single Nucleotide

Share to Transplantation, Homologous

Share to Young Adult

Source

Identifiers

PMID: 21628416
DOI: 10.1182/blood-2010-09-310011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.PMID 21628416Read ↗

Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.Semantic proximity Read ↗

Genetic risk factors for sclerotic graft-versus-host disease.Semantic proximity Read ↗

Biologic markers of chronic GVHD.Semantic proximity Read ↗

Personalized Medicine for Kidney Transplantation: Association of Graft Survival and Acute Transplant Rejection with Genetic Variation in B Cell Activating Factor System Signaling.Semantic proximity Read ↗

Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models.Semantic proximity Read ↗

Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease.Semantic proximity Read ↗

Novel HLA-DP region susceptibility loci associated with severe acute GvHD.Semantic proximity Read ↗

Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.Semantic proximity Read ↗

Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.Semantic proximity Read ↗

Genetics of risk factors for graft-versus-host disease.Semantic proximity Read ↗

Multiple single-nucleotide polymorphism-based risk model for clinical outcomes after allogeneic stem-cell transplantation, especially for acute graft-versus-host disease.Semantic proximity Read ↗

Roles of HLA-DRB107 :01 and HLA-B15 :01 in the risk of acute Graft Versus Host Disease in pediatric patients undergoing HSCTSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.